Drugs and Devices: Comparison of European and U.S. Approval Processes

JACC. Basic to Translational Science
Gail A Van Norman

Abstract

The regulation of medical drugs and devices involves competing goals of assuring safety and efficacy while providing rapid movement of innovative therapies through the investigative and regulatory processes as quickly as possible. The United States and the European Union approach these challenges in different ways. Whereas the United States has always relied on a strictly centralized process through 1 agency, the Food and Drug Administration (FDA), the European Commission synchronized the regulations of 28 different countries as they combined to create the European Union. The FDA historically developed as a consumer protection agency, whereas the regulations from the European Commission arose out of a need to harmonize inter-state commercial interests while preserving national "autonomy." Thus, whereas the FDA has the advantages of centralization and common rules, the European Union regulates medical drug and device approvals through a network of centralized and decentralized agencies throughout its member states. This study explores some of the similarities and differences in European and U.S. regulation of drugs and devices, and discusses challenges facing each.

References

Feb 5, 2000·The Journal of Hospital Infection·J Bright
Sep 19, 2001·British Journal of Clinical Pharmacology·D B Jefferys
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·H Randall
Feb 19, 2003·Journal of Clinical Epidemiology·Catherine H MacLeanUNKNOWN Southern California Evidence-Based Practice Center
Apr 19, 2003·International Journal of Technology Assessment in Health Care·Christa Altenstetter
Jul 1, 2004·Circulation·Aaron V KaplanMartin B Leon
Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Apr 17, 2007·The New England Journal of Medicine·Jerry Avorn
Sep 13, 2008·Nature Reviews. Drug Discovery·Hans-Georg EichlerAlasdair Breckenridge
Aug 13, 2009·Biomedical Instrumentation & Technology·Claire McKenna
Dec 15, 2010·Archives of Internal Medicine·Alain Braillon
Jan 6, 2011·Journal of Managed Care Pharmacy : JMCP·Burgunda V SweetDawn M Parsons
Feb 2, 2011·Nature Reviews. Drug Discovery·John Arrowsmith
Feb 16, 2011·Archives of Internal Medicine·Diana M ZuckermanSteven E Nissen
May 12, 2011·BMJ : British Medical Journal·Peter C Gøtzsche, Anders W Jørgensen
May 17, 2011·BMJ : British Medical Journal·Deborah Cohen, Matthew Billingsley
May 17, 2011·BMJ : British Medical Journal·C Di MarioM Degertekin
Aug 13, 2011·The New England Journal of Medicine·Gregory D Curfman, Rita F Redberg
Jan 13, 2012·BMJ : British Medical Journal·Carl Heneghan
Feb 16, 2012·The New England Journal of Medicine·Frederic S Resnic, Sharon-Lise T Normand
Feb 16, 2012·The New England Journal of Medicine·Robert G Hauser
Feb 16, 2012·The New England Journal of Medicine·Daniel B KramerAaron S Kesselheim
Mar 28, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Robert G HauserLinda Kallinen Retel
Apr 10, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jeffrey LiuSamir Saba
May 9, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Károly Kaszala, Kenneth A Ellenbogen
May 18, 2012·The New England Journal of Medicine·Nicholas S DowningJoseph S Ross
Jun 6, 2012·Archives of Internal Medicine·Bo WangNiteesh K Choudhry
Aug 3, 2012·The New England Journal of Medicine·Saptarshi Basu, John C Hassenplug
Aug 4, 2012·PLoS Medicine·Sanket S Dhruva, Rita F Redberg
Oct 26, 2012·BMJ : British Medical Journal·Deborah Cohen
Oct 26, 2012·BMJ : British Medical Journal·Peter McCulloch
Oct 26, 2012·BMJ : British Medical Journal·Deborah Cohen
Jan 11, 2013·The New England Journal of Medicine·Brent M ArdaughRita F Redberg
Jul 31, 2013·British Medical Bulletin·Bruce Campbell
Oct 18, 2013·BMJ : British Medical Journal·Deborah Cohen
Feb 18, 2014·Clinical Medicine : Journal of the Royal College of Physicians of London·Nassim Parvizi, Kent Woods
Mar 7, 2014·The Milbank Quarterly·Corinna Sorenson, Michael Drummond
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Andrew J M Boulton
Apr 10, 2014·BMJ : British Medical Journal·Ned Stafford
May 20, 2014·The American Journal of Cardiology·John C SombergJanos Molnar
Dec 30, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Gerald J Dal Pan, Peter R Arlett
Sep 8, 2015·European Journal of Internal Medicine·Rita BanziSilvio Garattini

❮ Previous
Next ❯

Citations

Jan 13, 2018·Neurosurgery·Pierce D NunleyMarcus B Stone
May 1, 2019·Nature Biomedical Engineering·Dale J WaterhouseSarah E Bohndiek
May 12, 2019·Sensors·Sumit Majumder, M Jamal Deen
Jul 19, 2019·Pharmacoepidemiology and Drug Safety·Josep PaneMiriam C J M Sturkenboom
Jun 25, 2019·Frontiers in Cardiovascular Medicine·Benjamin L ZhangFrederick J Schoen
Nov 30, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Jeffrey A CohenRuth Ann Marrie
Sep 20, 2019·Archives of Disease in Childhood·Suzy HuijghebaertMyriam Van Winckel
Jun 18, 2019·Advanced Materials·Nikita ObidinCanan Dagdeviren
Jul 2, 2020·Critical Reviews in Clinical Laboratory Sciences·Vinoth Kumar RajendranAnwar Sunna
Jan 5, 2020·Eye·Peter J Morgan-Warren, Jiten B Morarji
Oct 26, 2018·Stroke; a Journal of Cerebral Circulation·Larry B Goldstein
Aug 28, 2019·NPJ Digital Medicine·Wai Kent YeungIracema Leroi
Mar 24, 2020·Nature Biomedical Engineering·Shiko M Ben-MenahemJörg Goldhahn
Sep 29, 2020·Journal of Experimental Pharmacology·Paola RoglianiLuigino Calzetta
Feb 23, 2018·European Journal of Clinical Pharmacology·Minette-Joëlle ZeukengPascal Bonnabry
Aug 11, 2018·Frontiers in Bioengineering and Biotechnology·Houman SavojiMohsen Akbari
May 28, 2019·Frontiers in Bioengineering and Biotechnology·Benjamen T O'DonnellBruce A Bunnell
Aug 15, 2019·Intensive Care Medicine·Miet Schetz, Thomas Bein
Jun 6, 2018·Frontiers in Bioengineering and Biotechnology·Gloria Huerta-ÁngelesVladimir Velebný
Jun 27, 2019·American Journal of Clinical Pathology·Jonathan R Genzen
Dec 2, 2017·Bioengineering·Julia Catalán, Hannu Norppa
Apr 17, 2018·Médecine sciences : M/S·Catherine Le Galès
Jul 30, 2018·NeuroRehabilitation·Lynne M Weber, Joel Stein
Jan 28, 2021·Therapeutic Innovation & Regulatory Science·J LapièreN Albin
Feb 7, 2021·Materials·Irene Rubia-RodríguezDaniel Ortega
Nov 17, 2020·Frontiers in Plant Science·Daniel TuséJohannes Felix Buyel
Jan 22, 2021·Nature Reviews. Clinical Oncology·Michail IgnatiadisStefanie S Jeffrey
Mar 5, 2021·JMIR Formative Research·Samuel Bonet Olivencia, Farzan Sasangohar
Feb 23, 2021·Emergent Materials·Farzan Vahedifard, Krishnan Chakravarthy
Apr 11, 2021·Journal of Clinical Epidemiology·Hemalkumar B MehtaG Caleb Alexander
Aug 15, 2021·Advanced Drug Delivery Reviews·Dhara RaijadaNatalja Genina
Aug 28, 2021·Journal of Personalized Medicine·Bartha M KnoppersNora Pashayan
Feb 26, 2020·Digital Biomarkers·Andrea CoravosM Kelley Erb
Jan 2, 2021·Clinical Diabetes : a Publication of the American Diabetes Association·Kacie Doyle-Delgado, James J Chamberlain
Jan 16, 2022·Matrix Biology : Journal of the International Society for Matrix Biology·Alan J HibbittsFergal J O'Brien

❮ Previous
Next ❯

Methods Mentioned

BETA
amputations
PMA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.